MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

25 hedge funds and large institutions have $166K invested in Matinas BioPharma in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TSS
1
Two Sigma Securities
New York
$10.9K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$11.6K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$24.3K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$13.3K
5
CAM
5
Costello Asset Management
Pennsylvania
$104

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$31.1K
2
SIG
2
Sargent Investment Group
Maryland
$21.7K
3
UBS Group
3
UBS Group
Switzerland
$853
4
IA
4
IFP Advisors
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
– – -35 Closed
IA
27
IFP Advisors
Florida
– – -2 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2